期刊
MELANOMA RESEARCH
卷 31, 期 2, 页码 119-129出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CMR.0000000000000714
关键词
BRCA-associated protein-1; cutaneous melanoma; lung metastasis; tumor growth
资金
- National Natural Science Foundation of China [81773773, 81973357]
- Natural Science Foundation of Guangdong Province [1914050000120]
The study revealed an unexpected role of BAP1 in suppressing CM growth and metastasis through regulating gene expression and cellular functions. Deletion of BAP1 compromised colony-forming capability of CM cell lines and inhibited tumor growth and metastasis in animal models. BAP1 may serve as a potential therapeutic target for CM treatment.
Although germline mutations in BRCA-associated protein-1 (BAP1) predispose to cutaneous melanoma (CM), BAP1 is rarely mutated in primary CM outside the familial context. The role of BAP1 in the pathogenesis of CM remains obscure. Here, we discovered an unexpected role of BAP1 in suppressing CM growth and metastasis. BAP1 deletion by CRISPR-Cas9 system severely compromises colony-forming capability of murine CM cell line B16-F10 and human CM cell lines, SK-MEL-28 and A375. Furthermore, BAP1 loss abrogates tumor growth and lung metastasis in murine syngeneic tumor models. Deletion of BAP1 in B16-F10 cells leads to preferential downregulation of genes accompanied with increased H2A ubiquitination at lysine 119. Transcriptomic characterization of BAP1 deletion reveals multiple deregulated cellular functions including extracellular matrix-receptor interaction and MAPK signaling pathway which may contribute to BAP1's effect on metastasis and proliferation. Our findings indicate that BAP1 could be a potential therapeutic target for CM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据